ICUIICU MEDICAL INC/DE
- Market cap
- $4.17B
- as of 2026-10-23
- Latest close
- $166.62
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Medical Instruments & Supplies
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-01
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sanzone Virginia RuthVP, General Counsel | Sep 3 | Sep 3 | S | 2,202 | $167.67 | Sale −$369,209 | 17,258 | Yes | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Sep 3 | Sep 3 | S | 1,238 | $168.44 | Sale −$208,529 | 16,020 | Yes | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Sep 3 | Sep 3 | S | 724 | $169.53 | Sale −$122,740 | 15,296 | Yes | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Sep 3 | Sep 3 | S | 692 | $171.52 | Sale −$118,692 | 14,604 | Yes | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Sep 1 | Sep 1 | S | 6,381 | $175.00 | Sale −$1,116,675 | 56,062 | Yes | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Aug 31 | Aug 31 | S | 1,712 | $171.05 | Sale −$292,838 | 70,038 | Yes | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Aug 31 | Aug 31 | S | 1,914 | $172.12 | Sale −$329,438 | 68,124 | Yes | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Aug 31 | Aug 31 | S | 4,568 | $173.44 | Sale −$792,274 | 63,556 | Yes | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Aug 31 | Aug 31 | S | 1,113 | $173.91 | Sale −$193,562 | 62,443 | Yes | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Aug 13 | Aug 13 | S | 5,417 | $181.33 | Sale −$982,265 | 17,062 | No | Form 4 |
| Sousa BenChief Information Officer | Aug 12 | Aug 12 | S | 2,250 | $178.32 | Sale −$401,220 | 3,076 | No | Form 4 |
| Finney Elisha W | Aug 11 | Aug 11 | S | 378 | $182.48 | Sale −$68,977 | 4,871 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Aug 11 | Aug 11 | S | 8,929 | $182.93 | Sale −$1,633,382 | 37,377 | No | Form 4 |
| Woolson DanielPresident | May 22 | May 22 | S | 2,123 | $132.21 | Sale −$280,682 | 22,479 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | May 14 | May 15 | S | 2,447 | $124.08 | Sale −$303,624 | 19,460 | No | Form 4 |
| Finney Elisha W | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 5,249 | No | Form 4 |
| Finney Elisha W | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Finney Elisha W | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Hoffmeister David F | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 6,004 | No | Form 4 |
| Hoffmeister David F | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Hoffmeister David F | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Kennedy Kolleen T | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 4,539 | No | Form 4 |
| Kennedy Kolleen T | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Kennedy Kolleen T | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Abbey Donald | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 6,004 | No | Form 4 |
| Abbey Donald | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Abbey Donald | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Greenberg David C. | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 9,214 | No | Form 4 |
| Greenberg David C. | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Greenberg David C. | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Hernandez Laurie | May 13 | May 13 | M | 1,254 | $0.00 | $0 | 4,862 | No | Form 4 |
| Hernandez Laurie | May 13 | May 13 | M · derivative | 1,254 | $0.00 | $0 | not reported | No | Form 4 |
| Hernandez Laurie | May 13 | May 13 | A · derivative | 1,475 | $0.00 | $0 | 1,475 | No | Form 4 |
| Greenberg David C. | May 12 | May 13 | M | 2,424 | $101.06 | $244,969 | 10,384 | No | Form 4 |
| Greenberg David C. | May 12 | May 13 | S | 2,424 | $122.91 | Sale −$297,934 | 7,960 | No | Form 4 |
| Greenberg David C. | May 12 | May 13 | M · derivative | 2,424 | $101.06 | $244,969 | not reported | No | Form 4 |
| Abbey Donald | Mar 25 | Mar 26 | J | 704 | $0.00 | $0 | 4,046 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | M | 17,100 | $0.00 | $0 | 134,106 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | F | 9,452 | $125.85 | $1,189,534 | 124,654 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | M | 4,872 | $0.00 | $0 | 129,526 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | F | 2,693 | $125.85 | $338,914 | 126,833 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | M · derivative | 4,872 | $0.00 | $0 | not reported | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15 | Mar 16 | M · derivative | 17,100 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | M | 5,700 | $0.00 | $0 | 24,330 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | F | 3,150 | $125.85 | $396,428 | 21,180 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | M | 1,624 | $0.00 | $0 | 22,804 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | F | 897 | $125.85 | $112,887 | 21,907 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | M · derivative | 1,624 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15 | Mar 16 | M · derivative | 5,700 | $0.00 | $0 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15 | Mar 16 | M | 2,924 | $0.00 | $0 | 25,897 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15 | Mar 16 | F | 1,295 | $125.85 | $162,976 | 24,602 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15 | Mar 16 | M · derivative | 2,924 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | M | 11,400 | $0.00 | $0 | 51,154 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | F | 6,301 | $125.85 | $792,981 | 44,853 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | M | 3,248 | $0.00 | $0 | 48,101 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | F | 1,795 | $125.85 | $225,901 | 46,306 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | M · derivative | 3,248 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15 | Mar 16 | M · derivative | 11,400 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | M | 11,400 | $0.00 | $0 | 76,097 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | F | 5,800 | $125.85 | $729,930 | 70,297 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | M | 3,248 | $0.00 | $0 | 73,545 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | F | 1,795 | $125.85 | $225,901 | 71,750 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | M · derivative | 3,248 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15 | Mar 16 | M · derivative | 11,400 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15 | Mar 16 | M | 1,300 | $0.00 | $0 | 6,044 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15 | Mar 16 | F | 718 | $125.85 | $90,360 | 5,326 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15 | Mar 16 | M · derivative | 1,300 | $0.00 | $0 | not reported | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8 | Mar 9 | M | 107,635 | $0.00 | $0 | 176,506 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8 | Mar 9 | F | 59,500 | $132.00 | $7,854,000 | 117,006 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8 | Mar 9 | M · derivative | 107,635 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | M | 23,917 | $0.00 | $0 | 30,424 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | F | 13,221 | $132.00 | $1,745,172 | 17,203 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | M | 3,189 | $0.00 | $0 | 20,392 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | F | 1,762 | $132.00 | $232,584 | 18,630 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | M · derivative | 3,189 | $0.00 | $0 | 7,886 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8 | Mar 9 | M · derivative | 23,917 | $0.00 | $0 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | M | 16,147 | $0.00 | $0 | 28,327 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | F | 6,877 | $132.00 | $907,764 | 21,450 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | M | 2,153 | $0.00 | $0 | 23,603 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | F | 630 | $132.00 | $83,160 | 22,973 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | M · derivative | 2,153 | $0.00 | $0 | 6,908 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8 | Mar 9 | M · derivative | 16,147 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8 | Mar 9 | M | 71,757 | $0.00 | $0 | 79,421 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8 | Mar 9 | F | 39,667 | $132.00 | $5,236,044 | 39,754 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8 | Mar 9 | M · derivative | 71,757 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8 | Mar 9 | M | 71,757 | $0.00 | $0 | 104,364 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8 | Mar 9 | F | 39,667 | $132.00 | $5,236,044 | 64,697 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8 | Mar 9 | M · derivative | 71,757 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | M | 7,177 | $0.00 | $0 | 8,283 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | F | 3,967 | $132.00 | $523,644 | 4,316 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | M | 957 | $0.00 | $0 | 5,273 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | F | 529 | $132.00 | $69,828 | 4,744 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | M · derivative | 957 | $0.00 | $0 | 3,775 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8 | Mar 9 | M · derivative | 7,177 | $0.00 | $0 | not reported | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7 | Mar 9 | M | 5,282 | $0.00 | $0 | 71,790 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7 | Mar 9 | F | 2,919 | $0.00 | $0 | 68,871 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7 | Mar 9 | M · derivative | 5,282 | $0.00 | $0 | 10,566 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7 | Mar 9 | M | 2,348 | $0.00 | $0 | 7,804 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7 | Mar 9 | F | 1,297 | $132.00 | $171,204 | 6,507 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7 | Mar 9 | M · derivative | 2,348 | $0.00 | $0 | 11,075 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7 | Mar 9 | M | 1,585 | $0.00 | $0 | 12,882 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7 | Mar 9 | F | 702 | $132.00 | $92,664 | 12,180 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7 | Mar 9 | M · derivative | 1,585 | $0.00 | $0 | 3,170 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7 | Mar 9 | M | 3,522 | $0.00 | $0 | 9,610 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7 | Mar 9 | F | 1,946 | $132.00 | $256,872 | 7,664 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7 | Mar 9 | M · derivative | 3,522 | $0.00 | $0 | 7,044 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7 | Mar 9 | M | 3,522 | $0.00 | $0 | 33,870 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7 | Mar 9 | F | 1,263 | $0.00 | $0 | 32,607 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7 | Mar 9 | M · derivative | 3,522 | $0.00 | $0 | 7,044 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7 | Mar 9 | M | 1,409 | $0.00 | $0 | 1,888 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7 | Mar 9 | F | 782 | $132.00 | $103,224 | 1,106 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7 | Mar 9 | M · derivative | 1,409 | $0.00 | $0 | 4,732 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Nov 25, 2025 | Nov 25, 2025 | S | 2,897 | $152.35 | Sale −$441,358 | 11,297 | No | Form 4 |
| Finney Elisha W | Nov 11, 2025 | Nov 12, 2025 | M | 1,285 | $103.76 | $133,332 | 5,280 | No | Form 4 |
| Finney Elisha W | Nov 11, 2025 | Nov 12, 2025 | S | 1,285 | $140.42 | Sale −$180,440 | 3,995 | No | Form 4 |
| Finney Elisha W | Nov 11, 2025 | Nov 12, 2025 | M · derivative | 1,285 | $103.76 | $133,332 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Nov 11, 2025 | Nov 12, 2025 | S | 930 | $142.35 | Sale −$132,386 | 5,456 | No | Form 4 |
| Jain VivekChairman and CEO | Sep 12, 2025 | Sep 15, 2025 | G | 63,641 | $0.00 | $0 | 66,508 | No | Form 4 |
| Jain VivekChairman and CEO | Sep 12, 2025 | Sep 15, 2025 | G | 63,641 | $0.00 | $0 | 152,339 | No | Form 4 |
| Greenberg David C. | Aug 27, 2025 | Aug 27, 2025 | P | 602 | $126.14 | Purchase +$75,936 | 7,362 | No | Form 4 |
| Greenberg David C. | Aug 27, 2025 | Aug 27, 2025 | P | 598 | $126.69 | Purchase +$75,761 | 7,960 | No | Form 4 |
| Jain VivekChairman and CEO | Aug 14, 2025 | Aug 14, 2025 | P | 2,378 | $112.12 | Purchase +$266,621 | 110,598 | No | Form 4 |
| Jain VivekChairman and CEO | Aug 14, 2025 | Aug 14, 2025 | P | 19,551 | $112.92 | Purchase +$2,207,699 | 130,149 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | May 30, 2025 | May 30, 2025 | S | 700 | $133.62 | Sale −$93,534 | 6,386 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 28, 2025 | May 28, 2025 | M | 5,560 | $96.83 | $538,375 | 11,073 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 28, 2025 | May 28, 2025 | S | 4,985 | $128.50 | Sale −$640,573 | 6,088 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 28, 2025 | May 28, 2025 | M · derivative | 5,560 | $96.83 | $538,375 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 27, 2025 | May 28, 2025 | M | 5,555 | $96.83 | $537,891 | 10,458 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 27, 2025 | May 28, 2025 | S | 4,945 | $131.00 | Sale −$647,795 | 5,513 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 27, 2025 | May 28, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 5,560 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 23, 2025 | May 23, 2025 | M | 5,555 | $96.83 | $537,891 | 9,862 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 23, 2025 | May 23, 2025 | S | 4,959 | $130.00 | Sale −$644,670 | 4,903 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 23, 2025 | May 23, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 11,115 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 22, 2025 | May 23, 2025 | M | 5,555 | $96.83 | $537,891 | 9,266 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 22, 2025 | May 23, 2025 | S | 4,959 | $130.03 | Sale −$644,819 | 4,307 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 22, 2025 | May 23, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 16,670 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 21, 2025 | May 21, 2025 | M | 5,555 | $96.83 | $537,891 | 8,628 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 21, 2025 | May 21, 2025 | S | 4,917 | $133.00 | Sale −$653,961 | 3,711 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 21, 2025 | May 21, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 22,225 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 20, 2025 | May 21, 2025 | M | 5,555 | $96.83 | $537,891 | 7,944 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 20, 2025 | May 21, 2025 | S | 4,871 | $137.11 | Sale −$667,863 | 3,073 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 20, 2025 | May 21, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 27,780 | No | Form 4 |
| Finney Elisha W | May 19, 2025 | May 20, 2025 | S | 600 | $138.92 | Sale −$83,352 | 3,252 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 19, 2025 | May 19, 2025 | M | 5,555 | $96.83 | $537,891 | 7,944 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 19, 2025 | May 19, 2025 | S | 5,555 | $138.00 | Sale −$766,590 | 2,389 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 19, 2025 | May 19, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 33,335 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 16, 2025 | May 19, 2025 | M | 5,555 | $96.83 | $537,891 | 7,944 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 16, 2025 | May 19, 2025 | S | 5,555 | $140.00 | Sale −$777,700 | 2,389 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 16, 2025 | May 19, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 38,890 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 15, 2025 | May 15, 2025 | M | 5,555 | $96.83 | $537,891 | 7,944 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 15, 2025 | May 15, 2025 | S | 5,555 | $135.55 | Sale −$752,980 | 2,389 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 15, 2025 | May 15, 2025 | M · derivative | 5,555 | $96.83 | $537,891 | 44,445 | No | Form 4 |
| Sousa BenChief Information Officer | May 15, 2025 | May 15, 2025 | S | 2,000 | $137.36 | Sale −$274,720 | 479 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 14, 2025 | May 15, 2025 | M | 5,556 | $96.83 | $537,987 | 7,945 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 14, 2025 | May 15, 2025 | S | 5,556 | $138.65 | Sale −$770,339 | 2,389 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 14, 2025 | May 15, 2025 | M · derivative | 5,556 | $96.83 | $537,987 | 50,000 | No | Form 4 |
| Finney Elisha W | May 13, 2025 | May 14, 2025 | M | 1,723 | $0.00 | $0 | 3,852 | No | Form 4 |
| Finney Elisha W | May 13, 2025 | May 14, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Finney Elisha W | May 13, 2025 | May 14, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Abbey Donald | May 13, 2025 | May 13, 2025 | M | 1,723 | $0.00 | $0 | 4,750 | No | Form 4 |
| Abbey Donald | May 13, 2025 | May 13, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Abbey Donald | May 13, 2025 | May 13, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Hoffmeister David F | May 13, 2025 | May 13, 2025 | M | 1,723 | $0.00 | $0 | 4,750 | No | Form 4 |
| Hoffmeister David F | May 13, 2025 | May 13, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Hoffmeister David F | May 13, 2025 | May 13, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Kennedy Kolleen T | May 13, 2025 | May 13, 2025 | M | 1,723 | $0.00 | $0 | 3,285 | No | Form 4 |
| Kennedy Kolleen T | May 13, 2025 | May 13, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Kennedy Kolleen T | May 13, 2025 | May 13, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | M | 1,723 | $0.00 | $0 | 6,760 | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | M | 1,942 | $94.68 | $183,869 | 8,702 | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | S | 1,942 | $143.66 | Sale −$278,988 | 6,760 | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Greenberg David C. | May 13, 2025 | May 13, 2025 | M · derivative | 1,942 | $94.68 | $183,869 | not reported | No | Form 4 |
| Hernandez Laurie | May 13, 2025 | May 13, 2025 | M | 1,723 | $0.00 | $0 | 3,608 | No | Form 4 |
| Hernandez Laurie | May 13, 2025 | May 13, 2025 | M · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Hernandez Laurie | May 13, 2025 | May 13, 2025 | A · derivative | 1,254 | $0.00 | $0 | 1,254 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2025 | Mar 17, 2025 | M | 4,872 | $0.00 | $0 | 110,908 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2025 | Mar 17, 2025 | F | 2,688 | $143.45 | $385,594 | 108,220 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 4,872 | $0.00 | $0 | 4,872 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2025 | Mar 17, 2025 | M | 1,624 | $0.00 | $0 | 7,984 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2025 | Mar 17, 2025 | F | 898 | $143.45 | $128,818 | 7,086 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 1,624 | $0.00 | $0 | 1,624 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2025 | Mar 17, 2025 | M | 2,923 | $0.00 | $0 | 15,488 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2025 | Mar 17, 2025 | F | 1,294 | $143.45 | $185,624 | 14,194 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 2,923 | $0.00 | $0 | 2,924 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2025 | Mar 17, 2025 | M | 3,248 | $0.00 | $0 | 4,181 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2025 | Mar 17, 2025 | F | 1,792 | $143.45 | $257,062 | 2,389 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 3,248 | $0.00 | $0 | 3,248 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15, 2025 | Mar 17, 2025 | M | 3,248 | $0.00 | $0 | 30,348 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 3,248 | $0.00 | $0 | 3,248 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2025 | Mar 17, 2025 | M | 1,299 | $0.00 | $0 | 3,195 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2025 | Mar 17, 2025 | F | 716 | $143.45 | $102,710 | 2,479 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2025 | Mar 17, 2025 | M · derivative | 1,299 | $0.00 | $0 | 1,300 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2025 | Mar 14, 2025 | A · derivative | 15,848 | $0.00 | $0 | 15,848 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2025 | Mar 10, 2025 | M | 3,189 | $0.00 | $0 | 8,119 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2025 | Mar 10, 2025 | F | 1,759 | $141.97 | $249,725 | 6,360 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2025 | Mar 10, 2025 | M · derivative | 3,189 | $0.00 | $0 | 13,423 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2025 | Mar 10, 2025 | M | 2,153 | $0.00 | $0 | 13,518 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2025 | Mar 10, 2025 | F | 953 | $141.97 | $135,297 | 12,565 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2025 | Mar 10, 2025 | M · derivative | 2,153 | $0.00 | $0 | 9,061 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2025 | Mar 10, 2025 | M | 957 | $0.00 | $0 | 2,446 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2025 | Mar 10, 2025 | F | 550 | $141.97 | $78,084 | 1,896 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2025 | Mar 10, 2025 | M · derivative | 957 | $0.00 | $0 | 6,141 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2025 | Mar 10, 2025 | F | 1,775 | $0.00 | $0 | 102,818 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2025 | Mar 10, 2025 | M | 3,218 | $0.00 | $0 | 106,036 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 3,218 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2025 | Mar 10, 2025 | M | 1,073 | $0.00 | $0 | 5,555 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2025 | Mar 10, 2025 | F | 625 | $141.97 | $88,731 | 4,930 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 1,073 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 7,044 | $0.00 | $0 | 16,612 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2025 | Mar 10, 2025 | M | 966 | $0.00 | $0 | 11,832 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2025 | Mar 10, 2025 | F | 467 | $141.97 | $66,300 | 11,365 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 966 | $0.00 | $0 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 4,755 | $0.00 | $0 | 11,214 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2025 | Mar 10, 2025 | M | 2,146 | $0.00 | $0 | 2,146 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2025 | Mar 10, 2025 | F | 1,213 | $141.97 | $172,210 | 933 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 2,146 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 10,566 | $0.00 | $0 | 10,566 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2025 | Mar 10, 2025 | M | 2,146 | $0.00 | $0 | 27,100 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 2,146 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 10,566 | $0.00 | $0 | 10,566 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2025 | Mar 10, 2025 | M | 430 | $0.00 | $0 | 1,749 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2025 | Mar 10, 2025 | F | 260 | $141.97 | $36,912 | 1,489 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2025 | Mar 10, 2025 | M · derivative | 430 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 4,227 | $0.00 | $0 | 7,098 | No | Form 4 |
| Jain VivekChairman and CEO | Jan 2, 2025 | Jan 2, 2025 | M | 1,373 | $88.76 | $121,867 | 105,966 | Yes | Form 4 |
| Jain VivekChairman and CEO | Jan 2, 2025 | Jan 2, 2025 | S | 1,373 | $155.48 | Sale −$213,474 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Jan 2, 2025 | Jan 2, 2025 | M · derivative | 1,373 | $88.76 | $121,867 | not reported | Yes | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Dec 6, 2024 | Dec 6, 2024 | S | 2,241 | $156.25 | Sale −$350,156 | 10,866 | No | Form 4 |
| Jain VivekChairman and CEO | Dec 2, 2024 | Dec 2, 2024 | M | 12,000 | $88.76 | $1,065,120 | 116,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Dec 2, 2024 | Dec 2, 2024 | S | 3,672 | $162.29 | Sale −$595,929 | 112,921 | Yes | Form 4 |
| Jain VivekChairman and CEO | Dec 2, 2024 | Dec 2, 2024 | S | 8,250 | $163.18 | Sale −$1,346,235 | 104,671 | Yes | Form 4 |
| Jain VivekChairman and CEO | Dec 2, 2024 | Dec 2, 2024 | S | 78 | $163.96 | Sale −$12,789 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Dec 2, 2024 | Dec 2, 2024 | M · derivative | 12,000 | $88.76 | $1,065,120 | 1,373 | Yes | Form 4 |
| Greenberg David C. | Nov 27, 2024 | Nov 27, 2024 | M | 972 | $94.68 | $92,029 | 6,009 | No | Form 4 |
| Greenberg David C. | Nov 27, 2024 | Nov 27, 2024 | S | 972 | $158.11 | Sale −$153,683 | 5,037 | No | Form 4 |
| Greenberg David C. | Nov 27, 2024 | Nov 27, 2024 | M · derivative | 972 | $94.68 | $92,029 | 1,942 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 27, 2024 | Nov 27, 2024 | M | 1,430 | $96.83 | $138,467 | 1,430 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 27, 2024 | Nov 27, 2024 | S | 1,430 | $158.00 | Sale −$225,940 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 27, 2024 | Nov 27, 2024 | M · derivative | 1,430 | $96.83 | $138,467 | 55,556 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 26, 2024 | Nov 26, 2024 | M | 7,719 | $96.83 | $747,431 | 7,719 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 26, 2024 | Nov 26, 2024 | S | 7,513 | $159.09 | Sale −$1,195,243 | 206 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 26, 2024 | Nov 26, 2024 | S | 206 | $160.09 | Sale −$32,979 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 26, 2024 | Nov 26, 2024 | M · derivative | 7,719 | $96.83 | $747,431 | 56,986 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 25, 2024 | Nov 26, 2024 | M | 1,962 | $96.83 | $189,980 | 1,962 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 25, 2024 | Nov 26, 2024 | S | 1,962 | $169.08 | Sale −$331,735 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Nov 25, 2024 | Nov 26, 2024 | M · derivative | 1,962 | $96.83 | $189,980 | 64,705 | No | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | M | 12,000 | $88.76 | $1,065,120 | 116,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | S | 4,228 | $170.75 | Sale −$721,931 | 112,365 | Yes | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | S | 4,147 | $171.91 | Sale −$712,911 | 108,218 | Yes | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | S | 2,386 | $172.76 | Sale −$412,205 | 105,832 | Yes | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | S | 1,239 | $173.60 | Sale −$215,090 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Nov 1, 2024 | Nov 4, 2024 | M · derivative | 12,000 | $88.76 | $1,065,120 | 13,373 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | M | 12,000 | $88.76 | $1,065,120 | 116,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | S | 4,156 | $177.50 | Sale −$737,690 | 112,437 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | S | 3,681 | $178.49 | Sale −$657,022 | 108,756 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | S | 3,375 | $179.16 | Sale −$604,665 | 105,381 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | S | 788 | $180.48 | Sale −$142,218 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Oct 1, 2024 | Oct 1, 2024 | M · derivative | 12,000 | $88.76 | $1,065,120 | 25,373 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M | 3,755 | $88.76 | $333,294 | 108,348 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | S | 3,755 | $162.69 | Sale −$610,901 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M | 4,440 | $88.76 | $394,094 | 109,033 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | S | 4,440 | $163.59 | Sale −$726,340 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M | 3,805 | $88.76 | $337,732 | 108,398 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | S | 3,805 | $164.07 | Sale −$624,286 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M · derivative | 3,755 | $88.76 | $333,294 | 45,618 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M · derivative | 4,440 | $88.76 | $394,094 | 41,178 | Yes | Form 4 |
| Jain VivekChairman and CEO | Sep 3, 2024 | Sep 3, 2024 | M · derivative | 3,805 | $88.76 | $337,732 | 37,373 | Yes | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Aug 30, 2024 | Aug 30, 2024 | S | 2,502 | $163.22 | Sale −$408,376 | 13,107 | No | Form 4 |
| Jain VivekChairman and CEO | Aug 16, 2024 | Aug 16, 2024 | M | 12,000 | $88.76 | $1,065,120 | 116,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Aug 16, 2024 | Aug 16, 2024 | S | 12,000 | $156.04 | Sale −$1,872,480 | 104,593 | Yes | Form 4 |
| Jain VivekChairman and CEO | Aug 16, 2024 | Aug 16, 2024 | M · derivative | 12,000 | $88.76 | $1,065,120 | 49,373 | Yes | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Aug 8, 2024 | Aug 8, 2024 | S | 2,050 | $144.11 | Sale −$295,426 | 4,482 | Yes | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 30, 2024 | May 30, 2024 | S | 10,507 | $103.85 | Sale −$1,091,152 | 2,032 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | May 30, 2024 | May 30, 2024 | S | 2,032 | $104.49 | Sale −$212,324 | not reported | No | Form 4 |
| Finney Elisha W | May 16, 2024 | May 16, 2024 | S | 300 | $104.95 | Sale −$31,485 | 2,129 | No | Form 4 |
| Finney Elisha W | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 2,429 | No | Form 4 |
| Finney Elisha W | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Finney Elisha W | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Abbey Donald | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 3,027 | No | Form 4 |
| Abbey Donald | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Abbey Donald | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Kennedy Kolleen T | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 1,562 | No | Form 4 |
| Kennedy Kolleen T | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Kennedy Kolleen T | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Hoffmeister David F | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 3,027 | No | Form 4 |
| Hoffmeister David F | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | not reported | No | Form 4 |
| Hoffmeister David F | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Greenberg David C. | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 5,037 | No | Form 4 |
| Greenberg David C. | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Greenberg David C. | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | 1,723 | No | Form 4 |
| Hernandez Laurie | May 15, 2024 | May 15, 2024 | M | 948 | $0.00 | $0 | 1,885 | No | Form 4 |
| Hernandez Laurie | May 15, 2024 | May 15, 2024 | M · derivative | 948 | $0.00 | $0 | not reported | No | Form 4 |
| Hernandez Laurie | May 15, 2024 | May 15, 2024 | A · derivative | 1,723 | $0.00 | $0 | 1,723 | No | Form 4 |
| Sousa BenChief Information Officer | May 10, 2024 | May 10, 2024 | S | 2,000 | $105.55 | Sale −$211,100 | 1,319 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2024 | Mar 18, 2024 | M | 4,871 | $0.00 | $0 | 107,264 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2024 | Mar 18, 2024 | F | 2,671 | $98.08 | $261,972 | 104,593 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 4,871 | $0.00 | $0 | 9,744 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2024 | Mar 18, 2024 | M | 1,624 | $0.00 | $0 | 7,422 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2024 | Mar 18, 2024 | F | 890 | $98.08 | $87,291 | 6,532 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 1,624 | $0.00 | $0 | 3,248 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2024 | Mar 18, 2024 | M | 2,923 | $0.00 | $0 | 16,903 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2024 | Mar 18, 2024 | F | 1,294 | $98.08 | $126,916 | 15,609 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 2,923 | $0.00 | $0 | 5,847 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2024 | Mar 18, 2024 | M | 3,247 | $0.00 | $0 | 14,319 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2024 | Mar 18, 2024 | F | 1,780 | $98.08 | $174,582 | 12,539 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 3,247 | $0.00 | $0 | 6,496 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15, 2024 | Mar 18, 2024 | M | 3,247 | $0.00 | $0 | 26,734 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15, 2024 | Mar 18, 2024 | F | 1,780 | $98.08 | $174,582 | 24,954 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 3,247 | $0.00 | $0 | 6,496 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2024 | Mar 18, 2024 | M | 1,299 | $0.00 | $0 | 3,782 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2024 | Mar 18, 2024 | F | 463 | $98.08 | $45,411 | 3,319 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 15, 2024 | Mar 18, 2024 | M · derivative | 1,299 | $0.00 | $0 | 2,599 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 15, 2024 | Mar 15, 2024 | S | 791 | $98.27 | Sale −$77,732 | 13,980 | No | Form 4 |
| Lopez George A | Mar 14, 2024 | Mar 14, 2024 | S | 7,978 | $101.87 | Sale −$812,719 | 877,343 | No | Form 4 |
| Lopez George A | Mar 12, 2024 | Mar 14, 20244/A | S | 1,522 | $101.51 | Sale −$154,498 | 885,321 | No | Form 4/A |
| Lopez George A | Mar 12, 2024 | Mar 13, 2024 | S | 1,522 | $101.51 | Sale −$154,498 | 316,231 | No | Form 4 |
| Lopez George A | Mar 11, 2024 | Mar 13, 2024 | S | 1,890 | $104.22 | Sale −$196,976 | 317,753 | No | Form 4 |
| Lopez George A | Mar 8, 2024 | Mar 11, 2024 | S | 15,372 | $105.94 | Sale −$1,628,510 | 319,643 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | M | 2,525 | $0.00 | $0 | 100,015 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | F | 1,384 | $104.52 | $144,656 | 98,631 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | M | 8,331 | $0.00 | $0 | 106,962 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | F | 4,569 | $104.52 | $477,552 | 102,393 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 2,525 | $0.00 | $0 | not reported | No | Form 4 |
| Jain VivekChairman and CEO | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 8,331 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2024 | Mar 11, 2024 | S | 3,300 | $104.57 | Sale −$345,081 | 4,771 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2024 | Mar 11, 2024 | M | 2,273 | $0.00 | $0 | 7,044 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2024 | Mar 11, 2024 | F | 1,246 | $104.52 | $130,232 | 5,798 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2024 | Mar 11, 2024 | A · derivative | 9,568 | $0.00 | $0 | 9,568 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 2,273 | $0.00 | $0 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2024 | Mar 11, 2024 | M | 2,020 | $0.00 | $0 | 15,665 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2024 | Mar 11, 2024 | F | 894 | $104.52 | $93,441 | 14,771 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2024 | Mar 11, 2024 | A · derivative | 6,459 | $0.00 | $0 | 6,459 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 2,020 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | M | 2,210 | $0.00 | $0 | 8,993 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | F | 1,212 | $104.52 | $126,678 | 7,781 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | M | 7,289 | $0.00 | $0 | 15,070 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | F | 3,998 | $104.52 | $417,871 | 11,072 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 2,210 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 7,289 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | M | 2,210 | $0.00 | $0 | 21,408 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | F | 1,212 | $104.52 | $126,678 | 20,196 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | M | 7,289 | $0.00 | $0 | 27,485 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | F | 3,998 | $104.52 | $417,871 | 23,487 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 2,210 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 7,289 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2024 | Mar 11, 2024 | M | 674 | $0.00 | $0 | 2,723 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2024 | Mar 11, 2024 | F | 240 | $104.52 | $25,085 | 2,483 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2024 | Mar 11, 2024 | M · derivative | 674 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 8, 2024 | Mar 11, 2024 | A · derivative | 2,871 | $0.00 | $0 | 2,871 | No | Form 4 |
| Lopez George A | Mar 7, 2024 | Mar 11, 2024 | S | 18,954 | $105.77 | Sale −$2,004,765 | 335,015 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | M | 3,218 | $0.00 | $0 | 90,536 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | F | 1,764 | $105.39 | $185,908 | 88,772 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | M | 19,306 | $0.00 | $0 | 108,078 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | F | 10,588 | $105.39 | $1,115,869 | 97,490 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 3,218 | $0.00 | $0 | 3,218 | No | Form 4 |
| Jain VivekChairman and CEO | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 19,306 | $0.00 | $0 | not reported | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | M | 1,073 | $0.00 | $0 | 5,751 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | F | 587 | $105.39 | $61,864 | 5,164 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | M | 6,436 | $0.00 | $0 | 11,600 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | F | 3,529 | $105.39 | $371,921 | 8,071 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 1,073 | $0.00 | $0 | 1,073 | No | Form 4 |
| Sanzone Virginia RuthVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 6,436 | $0.00 | $0 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | M | 966 | $0.00 | $0 | 10,843 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | F | 426 | $105.39 | $44,896 | 10,417 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | M | 5,792 | $0.00 | $0 | 16,209 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | F | 2,564 | $105.39 | $270,220 | 13,645 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 966 | $0.00 | $0 | 966 | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 5,792 | $0.00 | $0 | not reported | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | M | 2,145 | $0.00 | $0 | 2,145 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | F | 1,175 | $105.39 | $123,833 | 970 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | M | 12,872 | $0.00 | $0 | 13,842 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | F | 7,059 | $105.39 | $743,948 | 6,783 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 2,145 | $0.00 | $0 | 2,146 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 12,872 | $0.00 | $0 | not reported | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | M | 2,145 | $0.00 | $0 | 14,560 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | F | 1,175 | $105.39 | $123,833 | 13,385 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | M | 12,872 | $0.00 | $0 | 26,257 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | F | 7,059 | $105.39 | $743,948 | 19,198 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 2,145 | $0.00 | $0 | 2,146 | No | Form 4 |
| Bonnell Brian MichaelChief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 12,872 | $0.00 | $0 | not reported | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | M | 429 | $0.00 | $0 | 552 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | F | 159 | $105.39 | $16,757 | 393 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | M | 2,574 | $0.00 | $0 | 2,967 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | F | 918 | $105.39 | $96,748 | 2,049 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 429 | $0.00 | $0 | 430 | No | Form 4 |
| Sousa BenChief Information Officer | Mar 7, 2024 | Mar 11, 2024 | M · derivative | 2,574 | $0.00 | $0 | not reported | No | Form 4 |
| Lopez George A | Mar 4, 2024 | Mar 11, 2024 | S | 7,051 | $106.79 | Sale −$752,976 | 353,969 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 4, 2024 | Mar 5, 2024 | S | 6,887 | $106.77 | Sale −$735,325 | 6,716 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 4, 2024 | Mar 5, 2024 | S | 6,497 | $107.60 | Sale −$699,077 | 219 | No | Form 4 |
| Voigtlander Christian B.Chief Operating Officer | Mar 4, 2024 | Mar 5, 2024 | S | 219 | $108.30 | Sale −$23,718 | not reported | No | Form 4 |
| Smiths Group Plc | Feb 29, 2024 | Mar 1, 2024 | S | 830,000 | $106.08 | Sale −$88,046,400 | 1,670,000 | No | Form 4 |
| Smiths Group International Holdings Ltd | Feb 29, 2024 | Mar 1, 2024 | S | 830,000 | $106.08 | Sale −$88,046,400 | 1,670,000 | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | M | 146,366 | $58.79 | $8,604,857 | 170,043 | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | F | 82,725 | $104.02 | $8,605,055 | 87,318 | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | M | 66,000 | $58.79 | $3,880,140 | 126,000 | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | F | 37,302 | $104.02 | $3,880,154 | 88,698 | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | M · derivative | 146,366 | $58.79 | $8,604,857 | not reported | No | Form 4 |
| Jain VivekChairman and CEO | Feb 12, 2024 | Feb 14, 2024 | M · derivative | 66,000 | $58.79 | $3,880,140 | not reported | No | Form 4 |
| Woolson DanielVP, GM-Infusion Capital | Dec 1, 2023 | Dec 1, 2023 | S | 1,729 | $88.03 | Sale −$152,204 | 9,877 | No | Form 4 |